Adherence to Extended Venous Thromboembolism Prophylaxis and Outcomes After Complex Gastrointestinal Oncologic Surgery

[1]  R. Bold,et al.  Evaluation of Adherence to Venous Thromboembolism Prophylaxis Guidelines Among US Adults After Pancreatic Cancer Surgery. , 2022, JAMA surgery.

[2]  C. Booth,et al.  Incidence, Timing, and Outcomes of Venous Thromboembolism in Patients Undergoing Surgery for Esophagogastric Cancer: A Population-Based Cohort Study , 2022, Annals of Surgical Oncology.

[3]  M. House,et al.  AHPBA guidelines for managing VTE prophylaxis and anticoagulation for pancreatic surgery. , 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

[4]  N. Gleeson,et al.  Patients’ experience and compliance with extended low molecular weight heparin prophylaxis post-surgery for gynecological cancer: a prospective observational study , 2019, International Journal of Gynecological Cancer.

[5]  Jonathan M. Hernandez,et al.  Practice patterns of VTE chemoprophylaxis after discharge following hepatic and pancreatic resections for cancer: A survey of hepatopancreatobiliary surgeons , 2019, Journal of Thrombosis and Thrombolysis.

[6]  B. Martin,et al.  Characteristics of Initial Prescription Episodes and Likelihood of Long-Term Opioid Use — United States, 2006–2015 , 2017, MMWR. Morbidity and mortality weekly report.

[7]  N. Geahchan,et al.  Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry , 2016, SpringerPlus.

[8]  S. Hendren,et al.  Variation in Hospital Thromboprophylaxis Practices for Abdominal Cancer Surgery , 2016, Annals of Surgical Oncology.

[9]  B. Martin,et al.  Net Clinical Benefits of Guidelines and Decision Tool Recommendations for Oral Anticoagulant Use among Patients with Atrial Fibrillation. , 2015, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[10]  Michael K Gould,et al.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. , 2012, Chest.

[11]  P. Prandoni,et al.  Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study , 2010, Journal of thrombosis and haemostasis : JTH.

[12]  Timothy M. Pawlik,et al.  Limitations of Claims and Registry Data in Surgical Oncology Research , 2008, Annals of Surgical Oncology.

[13]  L. Jørgensen,et al.  Prolonged prophylaxis with dalteparin to prevent late thromboembolic complications in patients undergoing major abdominal surgery: a multicenter randomized open‐label study , 2006, Journal of thrombosis and haemostasis : JTH.

[14]  Kenneth Hess,et al.  Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases , 2004, Annals of surgery.

[15]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[16]  D. Singer,et al.  Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study , 1999, Annals of Internal Medicine.

[17]  G. Raskob,et al.  The economic burden of incident venous thromboembolism in the United States: A review of estimated attributable healthcare costs. , 2016, Thrombosis research.

[18]  J. Vauthey,et al.  Venous Thromboembolism Prophylaxis in Liver Surgery , 2015, Journal of Gastrointestinal Surgery.

[19]  J. Caprini.  Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. , 2010, American journal of surgery.